Polar Capital Healthcare Opportunities Class I - Income (GBP)
41.00p
(0.67%)
41.00p
(0.67%)
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
41.00p
(0.67%)
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
Charges and Savings
| Initial charges | |
|---|---|
| Initial charge: | 5.00% |
| Initial saving from HL: | 5.00% |
| Net initial charge: | 0.00% |
| HL dealing charge: | Free |
| Annual charges | |||||
|---|---|---|---|---|---|
| Performance fee: | Yes View risks | ||||
| Ongoing charge (OCF/TER): | 1.13% | ||||
| Ongoing saving from HL: | 0.00% | ||||
| Net ongoing charge: | 1.13% | ||||
| There are other unit types of this fund available: | |||||
|
|||||
In some cases the ongoing savings are provided by our loyalty bonus. Loyalty bonuses are tax-free in an ISA or SIPP. However, they may be subject to tax in a Fund & Share Account which would, in effect, reduce their value and increase the net ongoing charge.
Other Information
Ready to invest?
To invest in , you'll need to have an account. Try our handy filter to explore the different options.
Ready to take your first step?
To invest in , you'll need to open an account. Try our handy filter and find out which suits you best.
Performance
| 20/12/19 to 20/12/20 | 20/12/20 to 20/12/21 | 20/12/21 to 20/12/22 | 20/12/22 to 20/12/23 | 20/12/23 to 20/12/24 | |
|---|---|---|---|---|---|
| Annual return | 15.89% | 4.03% | 6.18% | 0.34% | 13.69% |
Please remember past performance is not a guide to future returns. Where no data is shown, figures are not available. This information is provided to help you choose your own investments, remember they can fall as well as rise in value so you may not get back the original amount invested.
View fund chartOur view on this fund
The Wealth Shortlist features funds our analysts believe have the potential to outperform their peers over the long term. If a fund is not on the Shortlist, this is not a recommendation to sell; however, if you are thinking of adding to your investments, we believe the Wealth Shortlist is a good place to start. View funds on the Wealth Shortlist »
Fund Objective
The investment objective of the Fund is to preserve capital and achieve long term capital appreciation. The Fund will seek to achieve its investment objective by investing in a globally diversified portfolio of healthcare companies.
Income Details
| Security | Weight |
|---|---|
| ZEALAND PHARMA A/S | 7.86% |
| SWEDISH ORPHAN BIOVITRUM AB (PUBL) | 7.63% |
| UCB S.A. | 7.40% |
| ARGENX SE | 6.68% |
| NOVO NORDISK A/S | 6.36% |
| FRESENIUS SE & CO. KGAA | 4.16% |
| SANOFI | 4.01% |
| MAX INDIA LTD | 3.37% |
| SANDOZ GROUP AG | 3.35% |
| AVADEL PHARMACEUTICALS PUBLIC LIMITED COMPANY | 3.20% |
| Sector | Weight |
|---|---|
| Pharmaceuticals & Biotechnology | 75.38% |
| Medical Equipment & Services | 12.07% |
| Health Care Providers | 9.89% |
| Industrial Support Services | 2.63% |
| Personal Care, Drug & Grocery Stores | 2.02% |
| Cash and Equiv. | -1.99% |
| Country | Weight |
|---|---|
| United States | 24.69% |
| Denmark | 17.32% |
| Netherlands | 9.29% |
| Sweden | 7.63% |
| Belgium | 7.40% |
| Japan | 6.84% |
| India | 5.63% |
| Ireland | 5.22% |
| France | 4.54% |
| Germany | 4.16% |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by Morningstar, correct as at 19 December 2024. Data provided by Broadridge, correct as at 31 October 2024.
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
4 If you elect to receive the income from an ISA or a Fund & Share Account, we will collect any dividends for you and then pay them directly into your bank account within the first 10 working days of the following month.
